§ Federal grant opportunity · PAR-28-074
Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)
National Institutes of Health is accepting applications for Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required). The deadline is Rolling / not published and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- Rolling / not published
- Award range
- Award amount not published
- Eligibility
- nonprofits non higher education without 501c3, public and indian housing authorities, county governments, small businesses, public and state institutions of higher education, federally recognized native american tribal governments, for profit organizations other than small businesses, special district governments, private institutions of higher education, other native american tribal organizations, nonprofits non higher education with 501c3, city or township governments, state governments, other, independent school districts
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- PAR-28-074
Program overview
The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications that propose early to definitive clinical trials. Trials testing drugs, devices, biologics, procedures, behavioral, social, economic, health services, or other biomedical or non-pharmacological interventions are of interest to this initiative. The trials should align with the research mission of the participating Institutes, Centers, and Offices (ICOs) of the NIH. The NOFO will utilize the R61/R33 activity code, a bi-phasic, milestone-driven award. The R61 phase provides support for planning activities, and the R33 phase provides support for a clinical trial, with a maximum project period of 7 years. Applications are not being solicited at this time. This notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and relevant projects. Investigators with expertise in clinical trial planning, design, implementation, intervention development, and/or stakeholder engagement are encouraged to consider applying for the NOFO.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before Rolling / not published, allowing time for registration and validation.
Related grant opportunities
- Flexible Funding Model - Advancing Domestic Mutual Reliance Through Strengthened Infrastructure Development and Maintenance for Manufactured Food Regulatory Programs
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Therapeutic Agent Characterization and Preclinical Efficacy Studies
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification
- Global Collaborative Research Training on Non-Communicable Diseases and Disorders Across the Lifespan
- Atlanta FY 2021 – FY 2023 EDA Planning and Local Technical Assistance
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.